FdaApplication

ANDA 208773

Back to search

Identifiers

Properties

PropertyValue
applicant_nameHIKMA PHARMS
application_typeANDA
approval_date2020-05-15

Products (1)

ProductActive ingredientStrengthDosage form
POSACONAZOLEPOSACONAZOLE40MG/MLSUSPENSION;ORAL

1 product